Literature DB >> 6932068

Somatosensory evoked potentials and noxious stimulation in patients with intractable, noncancer pain syndromes.

R W Coger, B Kenton, J J Pinsky, B L Crue, A Carmon, Y Friedman.   

Abstract

Investigations of the evoked potentials (EPs) to noxious laser stimulation have indicated consistent strong linear relationships between subjective response (R), stimulus intensity (S), and EP amplitude (A). Thirty patients with chronic intractable benign pain syndromes (CIBPS) were tested to determine whether their patterns differed from previous studies with normal volunteers. Nearly half of the CIBPS patients were found to be relatively insensitive to acute pain stimuli. A large number were also found to show negative relationships between S and A. These differences from control subjects were considered of potential importance in their implications concerning the nature of chronic pain and its differences from the acute pain process.

Entities:  

Mesh:

Year:  1980        PMID: 6932068     DOI: 10.1016/0165-1781(80)90020-7

Source DB:  PubMed          Journal:  Psychiatry Res        ISSN: 0165-1781            Impact factor:   3.222


  4 in total

1.  Argon laser induced single cortical responses: a new method to quantify pre-pain and pain perceptions.

Authors:  P Bjerring; L Arendt-Nielsen
Journal:  J Neurol Neurosurg Psychiatry       Date:  1988-01       Impact factor: 10.154

2.  Sensory and pain threshold characteristics to laser stimuli.

Authors:  L Arendt-Nielsen; P Bjerring
Journal:  J Neurol Neurosurg Psychiatry       Date:  1988-01       Impact factor: 10.154

3.  First pain event related potentials to argon laser stimuli: recording and quantification.

Authors:  L Arendt-Nielsen
Journal:  J Neurol Neurosurg Psychiatry       Date:  1990-05       Impact factor: 10.154

4.  Second pain event related potentials to argon laser stimuli: recording and quantification.

Authors:  L Arendt-Nielsen
Journal:  J Neurol Neurosurg Psychiatry       Date:  1990-05       Impact factor: 10.154

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.